COP-RCT
Phase 4
- Conditions
- Cancer
- Registration Number
- JPRN-jRCT1030230265
- Lead Sponsor
- Miyazaki Sakiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Inclusion criteria
Previously diagnosed asymptomatic chemotherapy related cardiac dysfunction (CTRCD)
LVEF of >50%.
NYHA Class I
Current CTRCD therapy Angiotensin Converting Enzyme inhibitor (ACEi) plusminus Beta Blocker (BB)
Completed anthracycline AND HER2 receptor therapy
Exclusion Criteria
History of ischaemic heart disease
Hypertension requiring medical therapy
Moderate or greater severity valvular disease
Chronic kidney disease
Atrial, supraventricular, or ventricular arrhythmia requiring BB therapy
Pregnancy
under 16 years old
Contraindication to cardiac magnetic resonance imaging
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method